After reviewing many nominations for the Feel Beautiful Plastic Surgery 2013 Outstanding Product-Service Award, the judgment process has been concluded. This year, for the first time, the voting was unanimous. The winner is Julian Bakery of LaJolla, CA for their low carbohydrate and no carbohydrate high protein bread and pasta marketed online and in local Southern California retail stores. Alone among local bakeries, Julian’s innovative formulations stretch the definition of bread and pasta, and are extremely valuable additions to high performance and weight loss diets. Julian’s products increase compliance with weight control programs, and improve success rates. For more information, see JulianBakery.com.
Dr. Steve Laverson Receives the RealSelf 100 Award for Commitment to Patient Education in Social Media
San Diego Plastic Surgeon recognized as a top social media influencer on RealSelf – the world’s largest consumer source for cosmetic surgery information.
San Diego, CA – May 2, 2013 – Dr. Steve Laverson is one of 100 doctors to receive the RealSelf 100 Award, out of more than 5,000 board certified specialists. The award from RealSelf, the world’s largest consumer source for cosmetic surgery information is granted to Dr. Laverson for his commitment to ensuring millions of consumers get access to expert information about cosmetic procedures, treatments, and aesthetic concerns.
Dr. Laverson operates Feel Beautiful, a private Southern California Plastic Surgery known as the destination for “stealth” plastic surgery, naturally beautiful results that don’t look like plastic surgery. Stealth is Dr. Laverson’s philosophy, and incorporates original techniques. Features fundamental to your identity and beauty remain as they are. The stealth surgical procedure selectively manages only your problem areas. You don’t look different after stealth procedures; you still look like yourself, only better. Dr. Laverson has specialized in face, brow, and neck lift, eyelid rejuvenation, rhinoplasty, lip enhancement, facial aesthetic treatments, breast augmentation, breast lift, abdominoplasty (tummy tuck) and other aesthetic procedures for twenty years.
By providing personal responses to cosmetic surgery questions asked daily by RealSelf visitors, Dr. Laverson helps prospective patients from all over the world make confident decisions about plastic surgery and medicine. To date, Dr. Laverson has answered over one thousand questions and has received a rating of five out of five stars in RealSelf reviews.
“By routinely posting helpful answers and information for consumers, the RealSelf 100 doctors are setting the standard by which patients and physicians can engage thoughtfully on the social web without creating patient-doctor relationships,” commented RealSelf CEO Tom Seery. “We looked at our data and found that each RealSelf 100 doctor is building up a large base of fans and followers, which leads to significant inbound interest in their practices. That’s the power of social media and engagement with consumers.”
The United States Senate voted 79-20 as part of their 2014 budget to repeal part of the Affordable Care Act (Obamacare) that would have imposed a tax on medical-device sales, including breast and other implants. Repeal of the proposed medical device tax was bipartisan. Many Senators realize this provision would cost jobs at medical device producers. Additionally, the tax would increase cost of care and decrease availability of care, effects contrary to the intended purpose of the Affordable Care Act.
Revenue from the medical-device tax would have paid for part of the signature achievement of President Obama’s first term. Repeal of the tax does not become law because as part of a tax and spend 2014 budget bill passed by the Democrat controlled Senate, it stands no chance of passing the Republican controlled House of Representatives. Still, the symbolic vote is a victory for patients, physicians, and medical-device makers because it signifies overwhelming opposition to adverse impact of the medical-device tax. Sen. Amy Klobuchar (D., Minn.) said she opposed the tax, despite its connection to the health-care law. “It still isn’t right because it creates too much of a burden,” Sen. Klobuchar said, asserting the health-care overhaul won’t generate enough new customers to offset the costs for medical-device companies.
For both cosmetic implants and for breast reconstruction after mastectomy, the device tax would have increased costs, which are already among the highest worldwide due to the stifling regulatory and taxation environment in which American surgeons operate, and in which American patients are cared for. Facial and other body implants would also have been subject to additional taxation. Each and every regulatory board, agency, and committee that mandates accredited providers’ participation charges for that privilege. For the federal government to obligate cosmetic patients to pay for others’ medical care amounts to extortion, and to further abridgement of American liberty. The tax is contrary to constitutional principles, and for that reason alone, the measure should have been justly repealed.
Steve Laverson, MD
Dr. Laverson now using FDA approved “Gummy Bear” Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants for appropriate Breast Augmentation/Breast Enhancement San Diego Patients
After 15 plus years availability in Europe, recent FDA approval of Allergan highly cohesive gel implants now provide additional options for breast augmentation San Diego patients of Dr. Steve Laverson at the private Feel Beautiful Plastic Surgery Clinic in Encinitas, CA.
What are “Gummy Bear” Implants?
These breast implants have a solid silicone outer shell which is filled with silicone gel. The gel in Allergan’s “Gummy Bear” Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implant has additional polymer cross-links relative to gel in previously approved silicone gel-filled breast implants. Cross-linking refers to the bonds that link one silicone molecular chain to another. The higher level of silicone cross-linking results in a firmer gel. The term “gummy bear” refers to the semi-solid consistency of highly cohesive silicone gel, compared to viscous gel of regular breast implants. Traditional silicone gel implants have cohesive silicone gel which is very viscous, but changes shape more easily than form stable semi-solid highly cohesive “gummy bear” fill in the new Allergan Style 410 implants.
Other elements specific to highly cohesive breast implants are germane in selection of these devices. Because they are not as deformable, “gummy bear” implants may require a longer surgical incision than saline or less cohesive silicone gel-filled breast implants. Investigational studies identified “gel fracture” as a new phenomenon unique to highly cohesive silicone gel. Gel fracture is a long lasting fissure, or crack, of cohesive gel fill within an intact solid silicone breast implant shell. Although no patients have been adversely affected by gel fracture in studies conducted to date, post FDA approval studies will investigate gel fracture further.
Gummy bear implants are available in various sizes and shapes with granular surfaces that help grasp surrounding breast and chest tissue, immobilizing the implants where placed at the time of surgery by Dr. Laverson. Highly cohesive implants are also appropriate for revision surgeries, which correct or improve the result of an original breast augmentation San Diego procedure.
FDA Post-Approval Studies Summary:
As conditions of approval, the FDA required Allergan, Inc. to conduct four post-approval studies to characterize the long-term performance and safety of the devices. Post-approval investigation of Natrelle 410 Anatomically Shaped gummy bear silicone gel-filled breast implants included:
- US Post Approval Study- To document long-term results by enrolling more than 2,000 silicone gel-filled breast implant patients and following them for 10-years
- Case-Control Studies – To identify rare adverse events by enrolling 11,500 women in five case-control studies on rare connective tissue diseases, neurological diseases, brain cancer, cervical/vulvar cancer and lymphoma.
- Continued Access Study – To collect additional safety and effectiveness data from about 3,500 women who received these implants prior to approval but outside of the Core Cohort Study.
- Focus Group Study – To improve the format and content of the patient labeling.
In addition, explant analysis will be conducted for all Allergan Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants that are removed from patients and returned to the manufacturer.